Clinical Trial Update: The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating the pharmacodynamics and pharmacokinetics of evolocumab (a PCSK9 inhibitor) in patients with malignant glioma and gli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Duke University | Conditions: Malignant Glioma, Glioblastoma | EARLY_Phase 1 | Status: COMPLETED